Transformational Power of Genomics in Pharma: Strategic Intelligence
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Accelerating technologies within the genomics landscape:
Several advancements in the pharmaceutical industry have enabled the field of genomics to expand, with researchers innovating new means of therapy for patients with a wide variety of diseases, subsequently enabling in-depth insights to be generated within the genomics landscape. Genomics therapies are paving the way for novel treatments that address the root cause of diseases, allowing additional resources to be allocated for efficient precision and personalized medicine therapies for the treatment of rare diseases with niche and low patient populations.
Scope
A dedicated report examining the pivotal healthcare, technological, macroeconomic, and regulatory trends shaping the genomics field in pharma landscape. This report also provides an in-depth analysis of how these trends are poised to either accelerate progress or create obstacles for the growth of the genomics market.
Reasons to Buy
Understand the key trends accelerateing or hindering the genomics field in pharma space. See market forecasts for different therapies up to 2028. Understand recent and influential developments in genomics. Review of leaders and challengers across the genomics value chain.
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Genomics reports